ECOLAB INC.
For the period ended Sep 30, 2026. Filed Oct 29, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Oct 29, 2026
ECL$306.74+2.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
CONSOLIDATED BALANCE SHEETS
| (millions, except per share amounts) | September 302026 | December 312025 |
|---|---|---|
| ASSETS | ||
| Current assets | ||
| Cash and cash equivalents | $722.3 | $646.2 |
| Accounts receivable, net | 3,795.4 | 3,249.4 |
| Inventories | 1,764.8 | 1,490.4 |
| Other current assets | 817.4 | 569.6 |
| Total current assets | 7,099.9 | 5,955.6 |
| Property, plant and equipment, net | 4,595.4 | 4,276.6 |
| Goodwill | 12,687.6 | 9,227.0 |
| Other intangible assets, net | 5,098.5 | 3,688.5 |
| Operating lease assets | 752.0 | 765.9 |
| Other assets | 874.5 | 782.7 |
| Total assets | $31,107.9 | $24,696.3 |
| LIABILITIES AND EQUITY | ||
| Current liabilities | ||
| Short-term debt | $1,276.7 | $870.4 |
| Accounts payable | 2,339.5 | 2,071.0 |
| Compensation and benefits | 663.3 | 721.5 |
| Income taxes | 73.8 | 134.3 |
| Other current liabilities | 2,026.5 | 1,737.5 |
| Total current liabilities | 6,379.8 | 5,534.7 |
| Long-term debt | 11,915.3 | 7,365.9 |
| Pension and postretirement benefits | 530.9 | 546.1 |
| Deferred income taxes | 768.2 | 329.9 |
| Operating lease liabilities | 578.0 | 596.5 |
| Other liabilities | 481.2 | 518.7 |
| Total liabilities | 20,653.4 | 14,891.8 |
| Commitments and contingencies (Note 16) | ||
| Equity (a) | ||
| Common stock | 370.4 | 369.4 |
| Additional paid-in capital | 7,746.5 | 7,521.3 |
| Retained earnings | 13,737.3 | 12,834.0 |
| Accumulated other comprehensive loss | (1,680.4) | (1,874.3) |
| Treasury stock | (9,749.9) | (9,079.6) |
| Total Ecolab shareholders’ equity | 10,423.9 | 9,770.8 |
| Noncontrolling interest | 30.6 | 33.7 |
| Total equity | 10,454.5 | 9,804.5 |
| Total liabilities and equity | $31,107.9 | $24,696.3 |
(a)Common stock,800.0 shares authorized, $1.00 par value per share,280.5 shares outstanding as of September 30, 2026 and 282.0 shares outstanding as of December 31, 2025. Shares outstanding are net of treasury stock.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.